top of page
  • Facebook
  • Twitter
  • Linkedin

INVESTOR INFORMATION

Market Growth.png

COMPETITIVE ADVANTAGES

  • Leadership team that has founded, led, sold, and IPO'd device and biotech companies.

  • Large and growing market with substantial M&A activity

  • Strong IP Protection

  • Early revenue

ADDRESS UNMET MARKET NEEDS

​

  • CAPTOR MEDICAL is developing the CAPTOR™ technology for closely related medical device products to treat Acute Ischemic Stroke (AIS), addressing urgent clinical needs in the interventional radiology and cardiology markets - how to remove hard clot in AIS

  • Unlike other thrombectomy devices, the CAPTOR™ devices reliably remove not only soft clots but also hard clots

  • Unlike stent-retrievers and aspirators, CAPTOR™ devices reduce the risk of blood vessel wall damage and reduce the embolic clot fragmentation. 

LARGE MARKET OPPORTUNITY

  • The mechanical thrombectomy device market in 2019 is valued at $670 million worldwide, and is projected to grow between 6% and 8% per annum for the next decade.

bottom of page